BioAegis Therapeutics, Inc. Company Profile, Contacts & Intelligence

BioAegis Therapeutics, Inc. Overview

Commercializing Ground Breaking Discoveries in Inflammation and Infection BioAegis Therapeutics products restore plasma gelsolin, a human protein, whose important clinical role has been studied in animals and humans. Based on discoveries by Dr. Thomas Stossel and others, the body’s natural reservoir of plasma gelsolin keeps inflammation local, while its deficiency leads to inflammatory dysregulation and catastrophic consequences like multiple organ failure, shock and death. Systemic inflammation causes morbidity and mortality in a myriad of diseases including rare orphan indications and major acute and chronic diseases such as trauma, burns, renal disease and sepsis. Replacement of plasma gelsolin holds great promise for patients suffering from severe conditions with high unmet medical needs. BioAegis is developing high value, biomarker-directed treatments across a range of indications.

Headquarters

North Brunswick, New Jersey, United States

Website

bioaegistherapeutics.com

Industry

Biotechnology Research

Founded

2011

NAICS

Research and Development in Biotechnology (except Nanobiotechnology)

Phone Number

Available in AeroLeads

Company Email

Available in AeroLeads

BioAegis Therapeutics, Inc. Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

BioAegis Therapeutics, Inc. People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

BioAegis Therapeutics, Inc. Workforce Composition

Seniority breakdown across 5 visible profiles.

Compare Similar Companies to BioAegis Therapeutics, Inc.

Explore companies in related markets and compare their industry and employee estimates.